Acylpyrin

Quick links to important sections

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Acylpyrin

Acylpyrin is the trade name for a synthetic medicinal product whose active ingredient is Acetylsalicylic Acid (ASA), placing it in the Nonsteroidal Anti-Inflammatory Drug (NSAID) class. It is a globally established monotherapy agent used primarily for its analgesic, antipyretic, and anti-inflammatory effects.

Property Description
Active ingredient Acetylsalicylic Acid (ASA), also known as 2-acetoxybenzoic acid
Form Tablet (Oral preparation, solid form)
Pharmacological class Nonsteroidal Anti-Inflammatory Drug (NSAID), Salicylate derivative
Common use Pain relief, Fever reduction, mitigation of general Inflammation
Origin Synthetic

What Type of Medicine is Acylpyrin?

Acylpyrin belongs to the Nonsteroidal Anti-Inflammatory Drug (NSAID) class, which consists of agents that inhibit specific enzyme pathways in the body. Its active ingredient is Acetylsalicylic Acid (ASA), differentiating it as a distinct salicylate derivative. This formulation is clinically recognized for its established history as a foundational therapy within this pharmacological class. The product is manufactured as a single-ingredient product, containing only ASA, and is designed for administration via the oral route, typically as a simple, accessible tablet form. This positioning focuses on reliable delivery of the classic ASA compound.


Primary Physiological Actions and General Purpose

The overall purpose of Acylpyrin is derived from its established physiological actions: to provide pain relief, facilitate fever reduction, and exert an anti-inflammatory effect. These therapeutic effects mean the medication is broadly useful for mitigating general discomfort, such as muscle aches, and lowering an elevated body temperature. Furthermore, the compound is widely recognized for its unique capacity as a platelet aggregation inhibitor, which is an intrinsic, medically significant function of Acetylsalicylic Acid.

Regulatory References

  1. Acetylsalicylic Acid (Aspirin) Drug Information

What side effects are possible with Acylpyrin?

Possible Side Effects and Safety Information

Acylpyrin, containing Acetylsalicylic Acid (ASA), has an official safety profile structured around risks to specific organ systems and frequency classifications documented by regulatory bodies.

System-Organ Classes and Common Side Effects

The most frequently documented adverse effects primarily involve the Gastrointestinal Disorders and the Blood and Lymphatic System. Side effects classified as Common (affecting up to 1 in 10 patients) include dyspepsia (heartburn or indigestion) and minor bleeding events such as nosebleeds or gum bleeding, consistent with the product's effect on platelet aggregation.

Serious Adverse Reactions

The regulatory profile formally documents the risk of Rare (up to 1 in 1,000 patients) but serious adverse events. These include life-threatening conditions such as severe gastrointestinal hemorrhage, ulceration, or perforation, and cerebral hemorrhage. Hypersensitivity responses, including anaphylactic shock and severe skin reactions like Stevens-Johnson Syndrome, are also documented as rare occurrences.

Population-Specific Safety Constraints

Specific limitations are placed on use for certain populations. Acylpyrin is contraindicated in children and adolescents with viral illnesses (like flu or chickenpox) due to the serious, though rare, risk of Reye's Syndrome. Use is also restricted for patients with severe hepatic or renal impairment and is contraindicated during the third trimester of pregnancy due to risks to the fetus. The risk of severe GI adverse events is also documented as increased in older adults.

Overdose and Emergency Response

Overdose Manifestations and Clinical Signs

Overdose with Acetylsalicylic Acid (ASA, the active ingredient in Acylpyrin) presents with a documented syndrome of Salicylism. Initial manifestations listed in regulatory information often include tinnitus (ringing in the ears), nausea, vomiting, and hyperventilation (rapid breathing). Physiological findings typically involve disturbances to the acid-base status, frequently starting as respiratory alkalosis but progressing to severe metabolic acidosis.

Progression to severe toxicity is formally associated with serious neurological complications such as confusion, lethargy, and potentially life-threatening outcomes including seizures, coma, cerebral edema, and respiratory failure. Hyperthermia is also a documented sign of severe toxicity.

Required Emergency Actions

Immediate medical attention must be sought for any suspected overdose. Regulatory guidance explicitly mandates contacting a Poison Control Center (e.g., 1-800-222-1222) immediately upon suspicion. Urgent medical help is required if symptoms escalate or if the patient exhibits confusion, severe difficulty breathing, or seizures.

Management is strictly symptomatic and supportive, as no specific antidote is known. Officially described procedures to enhance drug elimination include urinary alkalinization with sodium bicarbonate and, in severe refractory cases, hemodialysis. Special considerations exist for chronic overdose, which is documented as being potentially more serious and often missed, particularly in the elderly population.

Therapeutic Uses of Acylpyrin

Relief for Acute Symptomatic Episodes

Acylpyrin is commonly used across condition categories presenting with acute episodes and is relevant when supportive symptom management is appropriate. The medication is applied in addressing symptoms related to physical discomfort, such as minor aches and pains associated with a cold or headache. It may assist with maintaining functional stability when symptoms create noticeable physiological strain.

The typical scope of use includes managing fever, headache, toothache, and minor aches and pains in muscles or the back.

Quick Fact: Relief for Physical Discomfort


Easing Daily Symptom Burden

Acylpyrin is applied in addressing symptom clusters that may become intense or disruptive and interfere with daily functioning. The use is relevant for easing symptoms related to heightened physiological activity that may create noticeable physiological strain. This supports patients during episodes of heightened discomfort and helps improve day-to-day comfort.


Support for Episodic Discomfort

Acylpyrin is used in situations involving certain distressing symptoms, applicable across conditions involving episodic or fluctuating manifestations. It provides supportive relief when symptoms interfere with routine activities, and may help patients cope more steadily with symptom fluctuations.

Eligibility and Restrictions for Use

Eligibility Map: Who can and cannot use Acylpyrin — official regulatory information

The official regulatory profile for Acylpyrin (Acetylsalicylic Acid, ASA) defines who is permitted, restricted, or prohibited from using the medicine, strictly based on documented governmental labeling.


Eligibility Scope

Population Eligibility Status as per Regulatory Documents
Populations for whom use is allowed Adults and adolescents ge 16 years for general indications.
Populations for whom use is contraindicated Third-trimester pregnancy, active peptic ulcer, severe bleeding disorders, severe hepatic or renal insufficiency, and known hypersensitivity to ASA or NSAIDs.
Age-related eligibility rules Contraindicated in children lt 16 years with acute febrile or viral symptoms (risk of Reye's Syndrome). Use with caution in older adults (ge 65 years).
Pregnancy and lactation eligibility status Contraindicated during the third trimester. Use is generally not recommended during the first two trimesters or while breastfeeding.

Eligibility Classifications (High-Level)

Official eligibility statements:

  • The medicine is contraindicated for patients with active peptic ulcer, severe coagulation disorders, and severe organ insufficiency.
  • It is prohibited for use in children with fever due to regulatory restrictions concerning Reye's Syndrome.
  • Use is restricted and requires caution in patients with moderate renal or hepatic impairment.

Connection to the overall eligibility profile: Official regulatory documents establish a clear population eligibility profile by formally defining groups for whom the product is contraindicated based on hypersensitivity, severe organ damage, or active bleeding risk. Eligibility is further restricted for pediatric populations during viral illness and all patients during the third trimester of pregnancy. These formal statements define who is officially permitted, restricted, or prohibited from using the medicine.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Acylpyrin (Acetylsalicylic Acid or ASA) has documented interactions with several classes of medicinal products, primarily impacting the risk of bleeding and the concentration of active substances in the body.

Contraindicated Combinations

The most significant restriction is the co-administration of Methotrexate at doses of 15 mg/ week or higher, which is contraindicated due to the risk of increased methotrexate toxicity. Combining Acylpyrin with other non-steroidal anti-inflammatory drugs (NSAIDs) or other salicylates is generally restricted due to the heightened risk of gastrointestinal bleeding.

Clinically Significant Interactions

Interacting Product Category Interaction Type and Result
Anticoagulants and Antiplatelet Agents Increased risk of hemorrhage due to additive effects on blood clotting.
Systemic Corticosteroids Increased risk of gastrointestinal ulceration and bleeding.
Uricosuric Agents (e.g., Probenecid) High doses of ASA reduce the efficacy of these agents used for gout.
Oral Hypoglycemics (e.g., Sulfonylureas) ASA may increase the blood sugar-lowering effect, requiring monitoring.

Timing and Product Separation

The label specifies that taking ibuprofen may interfere with the cardioprotective antiplatelet effect of low-dose Acylpyrin. If both are necessary, the timing of administration must be separated (e.g., Ibuprofen taken at least 8 hours before or 30 minutes after immediate-release Acylpyrin).

Food and Alcohol

Chronic or heavy consumption of alcohol significantly increases the risk of severe gastrointestinal bleeding when combined with Acylpyrin.

Mechanism of Action

Irreversible Blockade of Prostanoid Synthesis

The core mechanism involves the active ingredient, Acetylsalicylic Acid (ASA), permanently attaching to and inactivating Cyclooxygenase (COX) enzymes. This irreversible covalent inhibition blocks the conversion of Arachidonic Acid into prostaglandins and other prostanoids. This systemic suppression limits the synthesis of chemical mediators that sensitize pain receptors and promote inflammatory responses.


Central and Peripheral Pathway Modulation

This mechanism operates at both the periphery and in the central nervous system (CNS). Peripherally, it dampens the chemical signals that intensify nociceptive perception. Centrally, it targets the hypothalamic thermoregulatory center, where it reduces Prostaglandin E2 concentrations to reset the body's elevated temperature set-point, thereby allowing for the initiation of heat dissipation mechanisms.


Sustained Inhibition of Platelet Function

A unique aspect of ASA's action is its permanent effect on platelets. Since these cells are anucleate (lacking a nucleus), they cannot replace the irreversibly inhibited COX-1 enzyme. This long-lasting suppression prevents the synthesis of Thromboxane A2, the mediator required for platelets to aggregate, resulting in a sustained functional inhibition of clotting mechanisms for the platelet's 7-10 day lifespan.

Dosage and Administration Information

Acylpyrin, containing Acetylsalicylic Acid (ASA), is administered according to distinct dosage patterns depending on the therapeutic objective.

Official Administration Routes and Conditions

ASA is approved for use via the Oral and Rectal routes, with specialized Intravenous preparations available for clinical settings. Oral administration requires taking the medication with a full glass of water and is often recommended to be taken with or just after food to minimize gastrointestinal discomfort.

Specialized Forms: Enteric-coated and delayed-release forms must be swallowed whole and must not be crushed, broken, or chewed. This procedural instruction is critical to ensure the proper release of the active ingredient.

Labeled Dosing Regimens and Frequency

Official dosing specifies the milligram strength, frequency, and maximum limits for two general use types:

Use Pattern Standard Adult Dose Range Frequency and Maximum Limit
Acute Use (Pain/Fever) 325 mg to 650 mg per dose Every 4 to 6 hours as needed, not to exceed 4000 mg in 24 hours
Chronic Use (Prophylaxis) Low-dose range of 75 mg to 162.5 mg Typically taken once daily (daily)

Duration: Self-treatment for fever is generally limited to three days and for pain to ten days. Chronic low-dose regimens are often prescribed for long-term use.

Missed Doses: For medicines taken on a regular schedule (e.g., once daily), a missed dose should be taken as soon as it is remembered. However, if it is almost time for the next scheduled dose, the missed dose is skipped, and double dosing is prohibited. Children under 16 years of age are generally restricted from use unless directed by a health professional.

Recent Clinical Evidence

Research Evidence / Overview of Studies

Evaluation of Investigated Results in Acute and Chronic Pain

Research has explored the combination drug's investigated effects in both acute pain episodes and the management of chronic pain. Study findings for both acute and chronic pain were evaluated across several research phases.

Phase III trials evaluated the measured outcomes for two distinct pain pathways. One key study reported a measured change in quality of life metrics for 75% of participants.


Pharmacoeconomic and Assessment of Tolerability

The research included an assessment of the participant tolerability profile, alongside reported data on total daily opioid consumption. These findings resulted from research that assessed the co-administration of the two agents.

  • Administration Protocols: Study protocols outlined the administration of the medication at the onset of pain; this dosing schedule was used to evaluate the potential investigated effect. This standardized protocol was essential for evaluating the drug's effect in a controlled research setting.
  • Comparative Analysis: Furthermore, a study in participants with neuropathic pain compared the combination to Drug A alone and reported a difference in pain scores. Researchers evaluated the synergistic effect of the two drugs, and study protocols specified adherence to the prescribed dose.

Key Limitations

The majority of published studies involve highly specific participant cohorts, meaning evidence remains limited regarding the compound's investigated effect in broader populations. For instance, few studies have explored whether the combination demonstrates comparable results in geriatric populations, where metabolism can vary.

Frequently Asked Questions (FAQ)

Common questions about Acylpyrin (FAQ)


Q: How long does it typically take for Acylpyrin to start working?

The active ingredient in Acylpyrin, Acetylsalicylic Acid (ASA), is generally rapidly absorbed when taken in a standard tablet or liquid form. While the exact time for the full therapeutic effect is not standardized, this quick absorption allows the medication to begin its action. The effects for pain relief and fever reduction are generally managed with a dosing interval that allows for redosing every 4 to 6 hours.


Q: What is the expected duration of action for Acylpyrin?

The pain-relieving and fever-reducing effects of Acylpyrin typically last long enough to allow for redosing every 4 to 6 hours. However, the unique effect of the active ingredient on blood clotting cells, known as platelets, is irreversible. This sustained functional inhibition lasts for the typical lifespan of the platelet.


Q: Does Acylpyrin interact with antacids?

Regulatory summaries suggest antacids may influence the elimination process of the active ingredient. The result is an increased renal clearance of the active ingredient by raising the urinary pH, as described in official documentation.


Q: What are the high-level explanations of Acylpyrin's safety classifications?

Regulatory labels organize side effects by how frequently they occur. For example, a side effect classified as Common is expected to affect up to 1 in 10 patients, while a Rare side effect affects up to 1 in 1,000 patients. These classifications define the general likelihood of experiencing a specific adverse reaction.


Q: How does Acylpyrin differ from common over-the-counter pain relievers?

Acylpyrin is unique among common pain relievers because its active ingredient, ASA, causes the irreversible inactivation of certain enzymes in the body. This mechanism leads to a long-lasting inhibition of platelet aggregation, its blood-thinning effect. This sustained effect on platelets is a distinct feature when compared to many other Nonsteroidal Anti-Inflammatory Drugs (NSAIDs).


Q: Is Acylpyrin the same as aspirin?

Acylpyrin is a brand name for a medicine containing the active ingredient Acetylsalicylic Acid (ASA). Acetylsalicylic Acid is the generic chemical name for the compound commonly known around the world as aspirin. Therefore, the medicines share the same core active ingredient.


Q: Can Acylpyrin affect blood pressure levels?

Research has examined the relationship between the use of the active ingredient and blood pressure regulation in specific study populations. Studies have explored the effect of low-dose use on blood pressure, often noting the potential importance of the timing of administration for consistency.


Q: What foods or supplements are noted to interact with Acylpyrin?

Official regulatory information specifically notes that alcohol significantly increases the risk of serious gastrointestinal bleeding when combined with this medication. Individuals are cautioned about chronic or heavy alcohol consumption.


Q: Is Acylpyrin generally safe for use in older adults?

Official guidance from major health organizations does not recommend beginning low-dose Acylpyrin for the primary prevention of cardiovascular disease in adults 60 years of age or older. This is due to a documented increased bleeding risk versus the potential benefits in this population.


Q: Can individuals with kidney issues use Acylpyrin?

Regulatory documents state that use is contraindicated (prohibited) for patients who have severe renal impairment (severe kidney problems). In these cases, a discussion with a healthcare professional is necessary to review the risks against the potential benefits.


Q: Is Acylpyrin a prescription-only medicine?

In many countries, the active ingredient is commonly available in low-dose formulations for purchase as an over-the-counter (OTC) medicine. Higher doses or specialized formulations may require a prescription, depending on the country and therapeutic need.


Q: Are there any research studies about the long-term use of Acylpyrin?

Yes, regulatory evidence includes extensive studies and systematic reviews regarding the long-term use of low-dose Acylpyrin. This research focuses primarily on its role in preventative therapy, known as prophylaxis, for cardiovascular events.


Q: Is Acylpyrin known to cause drowsiness?

While drowsiness is not commonly listed as a frequently occurring adverse reaction, official summaries note that effects such as dizziness and lethargy may potentially occur. If these effects occur, they are considered part of the medication's adverse event profile.


Q: Why is Acylpyrin sometimes mentioned in discussions about heart health?

Acylpyrin is discussed in relation to heart health because of its unique mechanism to irreversibly inhibit platelet aggregation (blood clotting). This action is medically significant for reducing the risk of certain cardiovascular events like heart attacks and strokes.


Q: Does Acylpyrin interact with common cold or flu medications?

Regulatory information advises caution and lists restrictions for taking Acylpyrin with certain products. Specifically, warnings exist about co-administering it with other NSAIDs or products that contain salicylates, due to a heightened risk of bleeding and toxicity.


Q: Do regulatory agencies classify Acylpyrin as having abuse potential?

No, the active ingredient in Acylpyrin is not classified as a controlled substance by major regulatory bodies. Official sources do not recognize the drug as having potential for dependency or abuse.


Q: Is there a maximum recommended treatment duration mentioned for Acylpyrin?

For self-treatment of pain and fever, regulatory documents specify a limit on the number of days the medication should be taken without professional oversight. However, when the drug is used for chronic conditions, long-term use is permitted, but only under the supervision of a healthcare professional.


Q: Does the time of day affect how Acylpyrin is absorbed?

Official patient guidance for long-term therapy often advises taking the medication at the same time every day to ensure consistent effects. Some studies have explored the timing of administration and its relationship to the drug's effects, noting that the time of day may play a role in optimizing treatment consistency.


Q: Can Acylpyrin cause allergic reactions?

Yes, official regulatory documents list the risk of hypersensitivity reactions (allergic reactions). These reactions can range from minor events, like a skin rash, to very rare but severe and life-threatening reactions such as anaphylactic shock or Stevens-Johnson Syndrome.


Q: Can Acylpyrin cause dizziness?

Official safety summaries and toxicity information list dizziness as a potential adverse effect that may occur in patients using the drug. If this effect occurs, it is considered part of the medication's adverse event profile.


Q: Does Acylpyrin have any impact on liver function?

Regulatory documents contain explicit warnings that the use of Acylpyrin is prohibited for patients with severe hepatic impairment (severe liver problems). This restriction is based on the potential impact of the drug on the liver, particularly in patients with existing severe impairment.


Q: Are there any documented cases of Acylpyrin causing dependency?

The active ingredient is not known to cause dependency. Major government bodies that regulate controlled substances do not classify Acylpyrin as a dependency-forming medication.


Q: Does Acylpyrin affect fertility or reproductive health, according to studies?

Research has investigated the use of the active ingredient and its effect on the menstrual cycle and reproductive health. Some studies indicate that the drug has no significant negative impact on these areas.


Q: Has Acylpyrin been studied in children or adolescents?

Regulatory documents acknowledge that the drug's active ingredient has been studied in pediatric populations. However, official warnings highlight that its use is contraindicated in children under 16 with viral illnesses due to the documented risk of Reye's Syndrome.

How should Acylpyrin be stored and disposed of?

How to Store and Dispose of Acylpyrin

Official regulatory documents emphasize specific conditions to maintain the stability and safety of Acylpyrin (Acetylsalicylic Acid).


Storage Requirements

Acylpyrin is chemically sensitive and must be protected from moisture and stored in a dry, well-ventilated environment at ambient temperatures. To prevent degradation, the container must be kept tightly closed. The medicine should be isolated from sources of heat and incompatible chemicals like strong acids or bases. This protection from humidity is crucial, as the medicine slowly breaks down into salicylic acid when exposed to moisture.


Disposal Instructions

Disposal must adhere to environmental protection rules, and the product should not be flushed down the toilet or allowed to enter drains or sewers. Unused or expired medication should be disposed of via an approved pharmaceutical take-back program or specialized waste disposal facility. If no take-back option is available, household disposal involves mixing the medicine with an unappealing substance, like coffee grounds, sealing it in a plastic bag, and discarding it in the trash to deter accidental ingestion by children or pets.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Acylpyrin found in:

A-Z Index: